Company intelligence / Profile preview

Ensemble Group

Cambridge, Massachusetts, United States
Ownership
Private
Employees
~11
Development stage
Other
01

Overview

Ensemble internally developed novel synthetic macrocycle drugs (Ensemblins) for undruggable targets but did not advance any in-house drugs to late clinical stage. The IL-17 antagonist program was out-licensed to Novartis; other partnerships (Pfizer, Bristol Myers Squibb, Boehringer Ingelheim, Alexion, Genentech) focused on early discovery using macrocycle libraries. No programs reached commercialization under Ensemble's control

Therapeutic areas
OncologyNeurologyRare DiseasesImmunology
Modalities
Small moleculeSynthetic macrocycle
Industry
Biotech
02

Partnerships

Novartis (IL-17 antagonist, strategic development and licensing)Alexion Pharmaceuticals (protein-protein interaction discovery, milestone)Boehringer Ingelheim (macrocycle partnership)Pfizer (macrocycle drug discovery, PPIs)Bristol Myers Squibb (macrocycle drug discovery, PPIs)Genentech (macrocycle drug discovery, PPIs)

Beyond the preview

Go deeper on Ensemble Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ensemble Group.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call